Navigation Links
ADVENTRX Announces Appointment Of Chief Medical Officer
Date:8/14/2012

rical facts are forward-looking statements that are based on ADVENTRX's current expectations and assumptions. Such forward-looking statements include, but are not limited to, statements regarding Dr. Vetticaden's potential impact on the development of ANX-188, and the Company's development plans for ANX-188, including the nature and timing of future clinical studies. Among the factors that could cause or contribute to material differences between ADVENTRX's actual results and those indicated from the forward-looking statements are risks and uncertainties inherent in ADVENTRX's business, including, but not limited to: the potential for delays in the commencement or completion of planned clinical studies including as a result of difficulties or delays in completing manufacturing process development activities and manufacturing clinical trial material or difficulties or delays in obtaining regulatory agreement on clinical study design or meeting applicable regulatory requirements for clinical trial material; the risk of suspension or termination of a clinical study including due to lack of adequate funding; the risk that planned clinical studies are not successful and, even if they are successful, that the FDA could determine they are not sufficient to support an NDA for the product candidate; the potential for ADVENTRX to delay, reduce or discontinue current and/or planned development activities, including clinical studies, partner its product candidates at inopportune times or pursue less expensive but higher-risk development paths if it is unable to raise sufficient additional capital as needed; ADVENTRX's ability to obtain additional funding on a timely basis or on acceptable terms, or at all; the risk that the FDA does not grant marketing approval of ADVENTRX's product candidates, including ANX-188, on a timely basis, or at all; ADVENTRX's reliance on third parties to assist in the conduct of important aspects of its product candidates' development programs, inclu
'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Pharmaceuticals to Present at 1st Annual Sickle Cell Disease Therapeutics Conference
2. ADVENTRX Applauds Inclusion of Rare Diseases Provisions in the FDA Safety and Innovation Act
3. ADVENTRX Pharmaceuticals To Present At The OneMedForum New York 2012 Emerging Company Finance Conference On July 12
4. ADVENTRX Announces Manufacturing Agreement With Patheon to Manufacture ANX-188 Drug Product
5. ADVENTRX Pharmaceuticals To Present At 2012 BIO International Convention Business Forum
6. FDAnews Announces Medical Device Mobile Apps Virtual Conference
7. Dehaier Medical Announces 2012 Second Quarter and Six Month Financial Results
8. Isis Pharmaceuticals Announces Redemption Of 2 5/8% Convertible Subordinated Notes Due 2027
9. WuXi PharmaTech Announces Second-Quarter 2012 Results
10. Varian Medical Systems CEO Timothy E. Guertin Announces Plans to Retire; Board of Directors Names Dow R. Wilson as Successor
11. Comprehensive Care Corporation Announces Profitable Six Month Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015 ... EGFR mutation   is a viable alternative to tumour biopsy ... testing in all patients with advanced NSCLC   ... effectiveness of plasma circulating tumour DNA (ctDNA) testing for epidermal ... with advanced non-small cell lung cancer (NSCLC) in clinical practice. ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/5hkm2f/medical_oxygen ) has announced ... Global Strategic Business Report" report to their offering. ... Medical Oxygen Systems in US$ Thousands by the following ... Regulators, and Oxygen Conserving Devices. The report provides separate ... , Japan , Europe ...
(Date:4/17/2015)... DUBLIN , Apr. 16, 2015 Research and ... addition of the "Corporate Reputation of Pharma in ... 2nd edition" report to their offering. ... perspectives from 130 patient groups with an interest in ... companies (and of the pharma industry as a whole) ...
Breaking Medicine Technology:"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5
... MELVILLE, N.Y., April 23, 2012  Henry Schein, ... provider of health care products and services to dental, ... with the launch of its 2012 Global Reflections program ... "Henry Schein firmly believes that protecting ...
... Systems, Inc. (NASDAQ: DCTH ) today announced it ... revolver with Silicon Valley Bank ("SVB"), a leading provider of ... available for general corporate purposes supporting the overall growth and ... transaction, Eamonn P. Hobbs, President & CEO of Delcath Systems, ...
Cached Medicine Technology:Henry Schein Celebrates Earth Day 2Henry Schein Celebrates Earth Day 3Delcath Systems, Inc. Secures $20 Million Credit Facility 2Delcath Systems, Inc. Secures $20 Million Credit Facility 3Delcath Systems, Inc. Secures $20 Million Credit Facility 4
(Date:4/18/2015)... 18, 2015 More than 2000 styles ... at TheCelebrityDresses.com, the #1 online store carrying celebrity inspired ... girls have got their perfect dresses for their prom. ... fashion prom dresses at TheCelebrityDresses.com would be an ideal ... than 2000 prom dresses inspired by the most loved ...
(Date:4/18/2015)... Aureus Medical Group (web: aureusmedical.com), ... therapy jobs, has announced that it will participate ... Therapy Association Annual Conference to be held May ... SC. , The SCAPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
(Date:4/18/2015)... 18, 2015 PHOENIX, ARIZONA – In ... with 11 other secure destruction professionals across the United ... (CSDS). He will now display “CSDS” as a professional ... before the National Association of Information Destruction 2015 Annual ... Grapevine, Texas. Of the 20 people who took the ...
(Date:4/17/2015)... (PRWEB) April 18, 2015 Heritage Woods ... begin its Supportive Living Week Celebration on April 20 ... having a healthy mind, body and soul. , The ... McLeansboro, Illinois, serves older adults of all incomes, including ... their independence. , Supportive Living Week is observed every ...
(Date:4/17/2015)... NY (PRWEB) April 18, 2015 Rosetta ... their facility, rounding out their list of diagnostic imaging ... center for patients on the Upper East Side of ... running at full capacity. The addition of PET-CT, combined ... their physicians the ability to work with patients through ...
Breaking Medicine News(10 mins):Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3
... By Amanda Gardner HealthDay Reporter , MONDAY, ... pediatricians is calling for a ban on all junk food ... means of slowing the rising tide of obesity among young ... issue of Pediatrics , the American Academy of Pediatrics ...
... This release is available in German . ... more than one million euros in research and development funding ... at the research neutron source FRM II. In a 2009 ... the high neutron flux the neutron source in Garching can ...
... Hughes Medical Institute, the Max Planck Society and the ... a new, top-tier, open access journal for biomedical and ... establish a new journal that will attract and define ... All research published in the journal will make highly ...
... HealthDay Reporter , SUNDAY, June 26 (HealthDay News) -- ... lose weight, and low-fat diets that are either high in ... researchers say. "I think there are two key messages ... a senior lecturer with the school of medicine and health ...
... illicit drug used by teenagers and adults around the world. ... States report smoking it, and most high schoolers say they ... smoking pot is no big deal. They cite reasons such ... it." Denise Walker, co-director of the University of Washington,s ...
... tested a predatory bacterium Bdellovibrio against ... found that it significantly reduced the numbers of Salmonella ... safe when ingested. The research was funded by ... Professor Liz Sockett,s team at The University of Nottingham, with ...
Cached Medicine News:Health News:Doctors Urge Ban on Junk Food Ads During Kids' Shows 2Health News:Doctors Urge Ban on Junk Food Ads During Kids' Shows 3Health News:Cancer diagnosis isotopes from Garching 2Health News:Leading research organizations announce top-tier journal for biomedical and life sciences 2Health News:Calories, Not Protein or Carbs, Are Key to Weight Loss: Study 2Health News:Calories, Not Protein or Carbs, Are Key to Weight Loss: Study 3Health News:2 talks with teens leads to less marijuana use for at least a year 2Health News:2 talks with teens leads to less marijuana use for at least a year 3Health News:Living antibiotic effective against Salmonella 2
... comfortable lightweight brace is designed for ... ulnar fractures. The anatomically correct design ... compression for optimal control of ulnar ... elbow motion is permitted to prevent ...
... Blue Line Wrist Control offers a custom ... support for Carpal Tunnel Syndrome, tendinitis, sprains, ... wrist. Careful design leaves fingers free for ... Lightweight metal stay can be contoured for ...
... The RCAI Dorsal Blocking Splint is constructed of ... The DBS protects the flexor tendons of the ... prevents scar tissue development in the later stages ... rest dorsally on the hand and positions the ...
Used for fractures of the phalanges where extension is required. Used to immobilize the joint following dislocation. Curved to conform to the finger.Choose from four sizes 1.5", 2.5", 4" and 6". Unpa...
Medicine Products: